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Should Doctors Take Into Account Human Races?
A Medical Ethics Approach
Gabriel Andrade
Xavier University School of Medicine in Aruba
ABSTRACT
Racial determinations that lead to race-based treatments and mistreatments have many
harmful social effects. When used in the practice of medicine, can racial determinants
lead to good outcomes? This is an emerging question in medical ethics. It is undoubtedly
true that some individuals are more genetically prone to some diseases than others.
However, should one rush to judgment with the belief that race may be a valid indicator
in identifying diseases an individual is susceptible to? Furthermore, should race be
considered in prescribing treatment? Illnesses such as sickle cell-anemia and Tay Sachs
disease have long been thought to have a racial origin. This assumption is challenged in
this paper. There have also been attempts to prescribe specific drugs for specific racial
groups; but this is approach call for further inquiry. Belief in the presupposition that
disease is a bio-psycho-social process implies that genetic predispositions are only one
factor among many others that relate to the way things are socially constructed. This
paper seeks to critique one’s view of the use of race as a criterion of medicine to
prescribe treatment.

Key Words: Race, Medicine, Medical Discrimination, Disease, Health, Medical Ethics, Racial
Determinants

Editor’s Note: Kindly consider viewing Dr. Dorothy Robert’s Ted Talk: Race Based
Medicine as a follow-up to Andrade’s article:
https://www.ted.com/talks/dorothy_roberts_the_problem_with_race_based_medicine
Also consider viewing Dr. David William’s Ted Talk: How Racism Makes Us Sick
https://www.ted.com/talks/david_r_williams_how_racism_makes_us_.
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1. Introduction
In the wars that took place between English settlers and American Indians in the
eighteenth century, there was a very unfortunate episode. While British settlers were
besieging Fort Pitt (in the state of Pennsylvania, in the US), Jeffrey Amherst is said to
have derived the idea of giving the Indians blankets infected with smallpox. Amherst
reasoned smallpox would decimate the indigenous population, and so end the siege of the
fort and the conflict in general (Pedersen, 2010: 71).

History remains conflicted on the actual implementation of Amherest’s plan, but
he has remained in infamy as one of the pioneers of biological warfare. If, indeed, he
employed such a deliberate tactic, it may have killed half a million people. Whether it
was deliberate or not, the fact is that smallpox nearly annihilated the indigenous peoples
of America (Parker, Schutz, Meyer and Buller, 2010: 467). Often Spanish conquistadors
are accused of genocide, but in reality, most of the conquest of the Americas was done
with microbes. A few centuries before the arrival of Columbus to America, terrifying
plagues razed at least one third of the European population.
When Europeans came to America, they brought these diseases. It did not
constitute a serious threat to Europeans. But for indigenous people it was fatal because
they had never been in contact with them. They did not have a sufficiently strong
immunity. Anthropologist Jared Diamond (1999) suggested that the absence of
domesticated animals in the Americas gave Native Americans little contact with germs,
and this made them more likely to succumb to European diseases: smallpox, influenza,
measles, etc. .The result was tens of millions died in one of the most terrible epidemics
humanity has ever known.
One of the lessons of this tragic story is that some populations of the world are
more vulnerable than others to certain diseases. And in the same manner that amongst
populations there are varieties in height, skin color or frequency in the production of
lactase, there are also differences in genes encoding resistance to different types of
microbes. In the context of the conquest of America, smallpox became a disease
afflicting much more the natives (Robertson, 2001).
Thus, vulnerability to certain diseases can be used as a criterion for segmenting
humanity in different populations. And in the same way that some pseudoscientists have
tried to establish a correlation between skin color and other racial traits, as it was typical
in the nineteenth century during the heyday of racial science, it has also been postulated
that there is a correlation between racial traits and certain specific diseases.
Under this argument, select diseases are said to have a genetic basis. This is
similar to the opinion of some racialists that darker skin has a correlation with genes,
which encode with lower intelligence. As such, some racialists posit that racial traits are
correlated with genes encoding increased vulnerability to certain diseases
Thus, a catalog of racial diseases has been produced. Cystic fibrosis afflicts
particularly whites (Hopkin, 2010). Sickle cell anemia is a disease of blacks (Hill, 2003).
Tay-Sachs disease is almost exclusively Jewish (Walker, 2007). Tuberculosis incidence is
highest among Native Americans (Young, 1994). And, Gypsies have a disproportionate
percentage of patients with asthma (Greenfields, Darlymple and Fanning, 2011: 215).
And so it goes with many other diseases.
Unlike what happens in other spheres of social life, these racial labels supposedly
serve a laudable purpose: to make medical practice more effective. While postulating that
blacks are more inclined to crime is extremely destruction in that it promotes police
abuse; but, to postulate that blacks are much more vulnerable to sickle cell anemia, so the
argument goes, is supposed to be of great help. Consider, if a doctor sees a black patient
with some symptoms of this disease, it is supposed to be easier to make a diagnosis
(inasmuch as, given the racial profiling, it will be easier to rule out other diseases), and
attack the disease in quicker manner.

According to this argument, physicians should not only consider race when
developing diagnoses, but also administering drugs. The logic is conferred that racial
groups also have different responses to drugs.
2. The prospect of personalized medicine
Pharmacogenomics technologies, although in embryonic stages, offer the prospect
of being able to analyze the genome of a person and encode reactions to different drugs.
From this information, one should be able to make the determination of which
pharmacological agent will work best, and the dose to be administered.
These technologies are very promising, and if developed, would be a tremendous
medical breakthrough. Pharmacogenomics could offer the possibility of personalized
medicine. Each physician and other healthcare provider (i.e. nurse practitioners and
physician assistants) would indicate a detailed dose on the basis of genetic information of
each patient, and this would make more effective treatments (Innocenti, 2005).
Certainly, individualized medicine and dosing would be an ideal scenario. But, we
are still far from it. Until science finishes sequencing the complete genome of
individuals, we are very far from being able to follow this strategy. And, sequencing the
genome is just a first step; then comes the (much more difficult) procedure of specifying
in the genes different reactions to drugs.
Therefore, for now, personalized medicine is more a matter of science fiction than
real medical practice. However, in the meantime, there have been doctors who have
postulated that although we cannot yet offer individualized medical care, racial groups
can at least guide us. In that sense, if we have data that allow us to assume that certain
racial groups react better to some drugs and not others, then we can establish a
specialized racial allocation of some medications.
Psychiatrist Sally Satel, for example, admits that in surgery to repair a broken leg,
the patient's race is irrelevant. But when administering Fluoexetine, Satel chooses to
prescribe higher doses at baseline to white patients, and lower doses to black patients.
According to Satel, black patients metabolize antidepressants more slowly than white or
Asian patients, and thus, a high dose increases the risk of adverse reactions (Satel, 2008).
This racial discrimination in medicine is not exclusive of psychiatry. For years
there has been discussion about the possibility of drugs targeting specific races. And, in
2006, there was on the market a drug intended only for black patients, BiDil (Pollock,
2012: 165).
This drug is applied to treat heart disease. In the 1980s, tests were made with this
drug, and it was administered to different groups without a significant result. However,
blacks did demonstrate a significant improvement. Two decades later, tests were done
only with members of the black race, and positive results were documented in the
application of the drug. So, after these tests, US health authorities approved BiDil on the
market, only to be prescribed exclusively to blacks.
BiDil did not work well in the pharmaceutical market. But, it opened the door to
consider formulating drugs specifically aimed at racial groups. And, predictably, it has
sparked a controversy. Certainly the idea that there are human races has been very
harmful, but can this idea be used now to save lives? Should doctors take into account
human races?

3. Are there racial diseases?
The idea that there are diseases associated with specific races, and if this
proposition is true, that we can discriminate racially in the application of drugs, remains
ambiguous. First, it is doubtful that racial segmentation of diseases and their treatments
are always done with the laudable purpose of saving more lives. The practice of medicine
is a double-edged sword. Much good can be done, but medicine can also serve to
legitimize many abuses. And, as doctors often have the power to save lives, they also
have the power to strip freedoms to some groups in specific, all in the name of public
health. When a racial group is labeled with a specific disease, the compass is opened for
the social system, sponsored by the medical establishment, to impose greater
discrimination on a given particular group.
A racial group labeled with a disease can easily become a public menace, as it
allegedly has the danger of spreading the disease to the rest of society. If it’s not a
contagious disease, it has the danger of mixing their harmful genes with the rest of
society through miscegenation, and thus give rise to a sick generation. Or, the racial
group in question can become a heavy burden on the public health system because of its
increased vulnerability to certain diseases.
Departing from this, it is much easier to justify segregation systems as a kind of
permanent quarantine; or prohibit marriage between members of different racial groups
in order to prevent a race to become contaminated with harmful genes from the other; or
to forbid immigration in order to prevent immigrants from bringing their diseases and
make the public health system collapse.
Sickle cell anemia is a good example of how racial profiling in medicine can
bring dire social consequences. Since the beginning of the twentieth century in the US,
the idea that this disease afflicts blacks exclusively came up. Before the civil rights
movement in the 1960s, in the southern states, there was a terrible system of racial
segregation sanctioned by law (not unlike the South African apartheid). Under that
system, each individual was assigned a racial category, and this racial categorization
determined who could occupy seats on a bus, where they could eat, whom they could
marry, etc.
Under the one-drop-rule, a person was considered 'black', even if most of his or
her ancestors were white. It was enough to have one black ancestor, to be considered
black. In that sense, there was in the US a considerable segment of the population that,
for bureaucratic purposes, was black, but that might look white, and could even
circumvent the system of discrimination with their physical appearance. Amongst the
dominant white population, there was always a suspicion that some of their members
actually were not white, because there was a possibility that they had a black ancestor.
When a person suspected of being black was diagnosed with sickle cell anemia,
he or she was definitely assigned to the black race, which was a huge loss of privileges
and social prestige. In that sense, the racialization of medicine in that context was not
used to save more lives; rather, it served more to strengthen the system of racial
discrimination (Wailoo: 2001).
Much more serious was the experimentation that the US government did with
blacks suffering from syphilis, from the 1930s onwards. As often happens with AIDS
today, at that time there was a widespread belief that syphilis was a disease that
especially afflicted blacks, by virtue of their sexual transmission (racialists have come up

with several theories attributing blacks higher levels of sexual activity). Thus, the US
government organized the infamous Tuskegee experiments, which consisted in observing
black syphilis patients without their consent, to assess how the disease progressed
(Uschan, 2006).
It may be objected, of course, that the fact that a few decades ago, the
racialization of medicine was used to oppress, does not mean that today, it pursues the
same goal. But the fact is that many of the alleged racial diseases are not really such. In
many of these diseases some correlations have been established between high incidence
of certain diseases, and certain racial characteristics. But here again, the problem appears:
correlation is not the same as causation. Perhaps the correlation between skin color and
susceptibility to a specific disease, is due to a hidden variable we have not yet considered,
and in that sense, it would not be valid to postulate that this or that disease have racial
origin.
4. Sickle cell anemia and Tay Sachs disease
Consider again sickle cell anemia. This genetic disease is caused by the inability
of red blood cells to carry oxygen, and they acquire a shape like a sickle, instead of the
normal form, which is more like a disc. This generates circulatory problems, pulmonary
inflammations, cognitive functions, and especially less resistance against infections. Less
than 10% of patients who suffer it survive to adulthood.
In the popular imagination, it is a disease of the black race. And so it has been
frequently postulated that there must be a close relationship between the genes encoding
the typical racial characteristics used to identify blacks, and genes encoding sickle cell
anemia. But statistically, this disease is far from being exclusive of blacks. We find
significant frequencies in Mediterranean European countries, Arab countries and India.
According to conventional racial classifications, these populations belong to different
racial groups. So that cannot properly establish a causal relationship between a racial type
and the frequency of sickle cell anemia.
We must rather seek other variables. Geneticists have found a very significant
variable to explain why sickle cell anemia is most common in those regions. Today we
know that two copies of a gene encode this disease. However, when only a copy of that
gene is found, that encodes a considerable resistance to malaria (Zack, 2002:54).
Thus, in tropical regions traditionally affected by malaria, there is also a higher
frequency of sickle cell anemia. In these regions, it is advantageous to have a copy of the
gene in question, while encoding resistance to malaria. That facilitates an increase in the
frequency of that gene. But, by increasing the frequency of this gene, the frequency of
people born with two copies of the gene is also increased, and thus a higher frequency of
sickle cell anemia.
This puts in evidence that sickle cell anemia is not really a racial disease. There is
no direct relationship between dark skin and any specific sickness. There is, however, a
direct relationship between resistance to malaria and sickle cell anemia, and this has
meant that populations in tropical areas with more favorable weather conditions for
malaria also develop greater frequency of the allele encoding sickle cell anemia.
For example, in some regions of northern and eastern Africa, where there are not
favorable conditions for malaria (regions where the mosquito that transmits the parasite is
less abundant), such as in deserts or high altitude areas, the frequency of sickle cell

anemia is very low. Again, this is an indication that the disease is not associated itself
with racial traits (as the inhabitants of these areas, especially in eastern Africa, are
considered members of the black race), but instead with resistance to malaria.
There have been some racialists that think that the persistence of sickle cell
anemia in populations traditionally not considered black actually is due to mixtures with
black populations in the past (Tapper, 1999:25). For example, to explain why in Spain
(whose population is not considered black) there is a higher frequency of this disease
(compared to other European countries), it has been argued that this was due to the
introduction of black population during times of Al-Andalus, and even going back to the
time of Hannibal! Again, these explanations fail to consider that this disease has a
relationship, not with skin color or other racial traits, but with the vulnerability of the
Mediterranean region to malaria, especially since the beginnings of agriculture (as it was
during this time when, by paving the forests to make way for agricultural fields, the
mosquito found a favorable niche).
Tay-Sachs disease is another one that has been commonly racialized. This disease
is caused by a genetic mutation that affects the production of an enzyme that regulates the
level of lipids in the brain and nervous system. This leads to a neurological impairment,
and its symptoms are red spots on the retina, disproportionate head growth and mental
retardation, among others. This disease is encoded similarly to sickle cell anemia: to be
expressed, there must be two copies of the gene.
Initially, it was reported that the disease afflicted especially Ashkenazi Jews (Jews
from Eastern Europe). Then it was postulated that the disease was almost exclusively
Jewish, and that it was the result of crossbreeding between relatives (this disease is
encoded by a recessive allele, and this type allele is more common in descendants of
closer inbreeding).
Some racialists believe that that the high level of intelligence amongst Jews is
attributable to their genetic composition, which has resulted from their refusal to
interbreed with other populations: racialist Kevin MacDonald (2002: 293) even thinks
that from early on this was a deliberate Jewish eugenic strategy. Several authors have
also postulated that Tay-Sachs disease has a relationship with intelligence (analogous to
the relationship between resistance to malaria and sickle cell anemia): two copies of the
gene encode Tay-Sachs disease, but a copy of the gene could encode higher levels of
intelligence, and that would explain why Ashkenazi Jews are so smart (Ostter, 2012).
This comes from a genetic phenomenon called 'heterozygote advantage'. When
considering diseases such as sickle cell anemia or Tay-Sachs, an enigma arises: how do
these conditions persist in the population? Why has natural selection not definitively
destroyed the genes that encode them? An answer has been provided: because these
diseases are generated by recessive alleles. Genes encoding these diseases must also
encode a variant in some advantage in heterozygous alleles.
In the case of Tay-Sachs disease and others afflicting especially the Jews, it has
been postulated that their heterozygote advantage is a higher degree of intelligence. But
this seems to be a hasty conclusion. Until now, geneticists have only established
Ashkenazi correlation between high frequency of genes for Tay-Sachs (and other
diseases), and high level of intelligence. This in no way proves that these same genes
encode a high level of intelligence.

Moreover, it is not entirely clear that Tay-Sachs is a "Jewish disease". First, it is
difficult to accept that there is a "Jewish race": although there is some debate on this
topic, most geneticists agree that Jews are an ethnic group with no particularly important
genetic markers. While there are some genetic similarities among Jews, they do not share
a number of well-defined biological features that enable them to be labeled a racial group
(Corcos, 2005). And, in no way is Tay-Sachs a disease unique to Jews. Today (thanks to
genetic testing) it is virtually eradicated among the Jews, and it afflicts more other
populations.
5. Special drugs for each race?
Just as it is not entirely appropriate to postulate that there are racial diseases, it is
not entirely appropriate to postulate that some drugs should be reserved for specific races.
It is worth remembering that the hope of pharmacogenomics is to eventually set up a
personalized medicine. While we get to that stage (and, I am optimistic that someday we
will get there), some doctors advocate the use of racial categories as a guide to form an
idea of which drug works best in individuals. But even Sally Satel (the psychiatrist who
admits to offering different drugs to blacks and whites) warns that race is a very
rudimentary guide, and that the extent of racial profiling in medicine is very limited.
The case of the drug BiDil is illustrative. BiDil scored well in tests with black
patients. However, from the outset these tests were subject to objections, and they were
criticized because there was no sufficient control studies with white patients (or other
racial groups), in order to isolate the racial variable accordingly (Pollock 2012:165). But
also there is another fundamental objection: patients who were part of the study were
black, only to the extent that they self-defined as such. In other words, their racial
affiliation was conditioned by the social construction that stipulates the rules of who
belongs to any given racial group. This is clearly a sampling bias.
It is worth remembering that in the US (the country where BiDil was marketed),
traditionally a person is considered 'black' if just one of his or her ancestors is black (the
so-called one-drop-rule). Barack Obama is considered the first black US president, but in
reality, Obama is the son of a white woman (in Brazil, for example, he would not be
considered black), and in addition, his father was a native of East Africa, a region
different from the one whence slaves came to America. If someone like Obama had
participated in the test BiDil, he would surely have been identified as 'black'. But this
could alter the results, because under another social convention (such as the one used in
Brazil), Obama may have been well placed in the group of whites, and his positive
response to BiDil would have been counted among white patients who react well to this
drug, and not among black patients.
That does not mean that racial profiling in medicine has absolutely no value,
because perhaps Sally Satel is right when she argues that even if race is a very
rudimentary guide to form an idea of the genome of a patient, it is at least one tool
preferable to having no guide. Even if he does not accept the existence of human races,
commentator Kenan Malik argues that many of the ways in which we group people, are
not entirely arbitrary from a biological point of view, and we can have some confidence
that members of some racial groups retain more genetic proximity to each other than two
randomly selected individuals (Malik, 2009: 37).

But racialized medicine also has risks, and it therefore should be taken with
extreme caution. These risks are not merely the dangers of social oppression to which I
have already referred. There is also the risk that racialized medicine may cultivate
stereotypes that prevent optimal diagnosis and appropriate allocation of drugs, precisely
because if there is suspicion that an individual has this or that disease, a racial group may
be socially stigmatized with that disease. For example, in the US, there are many
documented cases of individuals who have been diagnosed too late with sickle cell
anemia (significantly reducing their quality of life), because they did not belong to the
black race, and their racial affiliation did not raise suspicion among treating physicians,
to take note of symptomatology.
6. Disease as a biopsychosocial process
Sickle cell anemia and Tay Sachs disease are completely determined by genetics.
However, there are many other diseases that have only a partial genetic basis, and many
environmental variables influence their manifestation and development. However, since
it is presumed that these diseases have a genetic basis, it has also been relatively common
to attribute them to specific racial groups, because of their genetic makeup.
In the US, for example, it is a common idea that blacks have a genetic
predisposition to hypertension, Hispanics are predisposed to diabetes, and Native Indians
are predisposed to alcoholism. In Latin America, there is also the idea that Native
Indians, by virtue of their genetic makeup, are much more susceptible to tuberculosis
than the rest of the population.
Sometimes racialists have formed curious theories about why some groups are
more vulnerable than others to certain diseases. In the case of indigenous peoples of
America, it has been postulated that their weak immunity against pathogens from Asia
and Europe explains why today they suffer disproportionately from diseases such as
tuberculosis. Certainly, this theory is adequate to explain why the Native American
population in less than a century, was decimated following the arrival of Europeans. But
it is doubtful that five centuries later, it serves to explain why Native Americans still
suffer from tuberculosis in large numbers (there is also the possibility that tuberculosis
was already in America before the arrival of Columbus (Finer: 2009: 14)). Precisely, after
that original epidemic upon contact with Europeans, the most fit survived, and their
descendants are today's Native Americans; however, they continue to suffer from
contagious diseases at higher rates than the rest of the population.
It has also been said that blacks in the Americas (but especially the US) suffer
from hypertension and other heart disease in higher rates compared to other groups,
because they are genetically programmed to retain more sodium. According to this
theory, in West Africa there were not enough sources of salt, and so in these populations,
natural selection favored those who retained sodium (Kiple, 2002:46). During the brutal
middle passage to America in slave ships, those who survived were the ones who were
better able to retain sodium. And, being slaves in America, the conditions to which they
were subjected (work in hot and humid climates) again promoted that natural selection
favored those who were able to retain more sodium.
The theory is ingenious, but it is very questionable and unsupported by data. First,
it is false that in West Africa there were no sources of salt. Many populations which were

then subject to slavery lived near the coast, and there, they were able to accumulate salt
reserves. In fact, populations in West African countries have low blood pressure rates.
In addition, death in voyages on slave ships was not due to diarrhea (associated
with dehydration and an inability to retain sodium), but mainly due to respiratory
diseases. And if in the warm humid climates plantations, those who survived were the
ones that better retained sodium, then one would expect that this applies not only to
blacks, but also to whites, i.e., descendants of the masters who lived in those climates.
It is true that there are some diseases afflicting more some racial groups than
others. And in general, this is reflected in a considerable difference in the levels of health
and life expectancy between racial groups. But again, correlation does not imply
causation. We must not rush to postulate that racial constitution is the reason why
members of some groups get sicker and live longer than members of other groups. It is
necessary to consider other variables.
Some racialists have assumed that the differential in vulnerability to disease and,
especially, life expectancy, is caused by racial differences. J.P. Rushton tries to explain
this fact in light of his racialist theories. According to his theory of r / k selection, in
populations that evolved in Africa, due to the instability of the habitat, natural selection
favored the strategy that consisted in having high fertility rates, lower intelligence, and
less care of the young (Rushton, 1995). This strategy focused more on fertility, and in this
sense, longevity was not a great advantage, and life cycles of African populations are
shorter. That explains why blacks have lower life expectancy and are more vulnerable to
many diseases.
Rushton’s hypothesis on life expectancy is ad hoc. This theory lacks empirical
support; it is true that in our society, blacks have a lower life expectancy; but this statistic
only establishes a correlation, not a causation (and thus, it does not prove Rushton’s
hypothesis). There is the possibility that the lower life expectancy of blacks is due to
other factors, which Rushton has not noticed.
Another racialist theory aims to locate a genetic origin for the racial disparity in
life expectancy, not exactly in physiology, but in intelligence. Biologist Satoshi
Kanazawa has documented a correlation between IQ and life expectancy: not
surprisingly, sub-Saharan countries, those with lower IQ level, have the lowest life
expectancy in the planet (Kanzawa, 2016). According to Kanazawa’s theory, in our urban
society, outside the context of the African savanna in which the human species
originated, the highest levels of health and life expectancy depend on high levels of
intelligence, as we face situations which our body is not adapted to, and information
processing is required to overcome new obstacles. Lower levels of intelligence promote
habits and behaviors that end up being harmful to health. And so, by transitivity, if some
racial groups are genetically programmed to have a lower level of intelligence, then they
are also genetically programmed to have lower life expectancy.
The data Kanazawa offers is not disputed. Indeed, besides the correlations he has
established, it has been documented that there is an inverse correlation between IQ level
and consumption of junk food, cigarettes, drugs and alcohol. But again, this just
documents a correlation, not causality. Kanazawa assumes that IQ is fixed and
determined genetically; this has been subject to intense criticism (Gould, 2006). It is
possible to postulate that many social conditions (including racism and oppression) may
cause lower levels of intelligence (assuming that IQ is an optimal measure of intelligence,

anyway) of some groups, and that this leads to lower life expectancy. Under this scenario,
not genetic constitution, but instead social conditions, cause some groups to have better
health indicators and life expectancy than others.
In fact, this is how we must understand the health differential between racial
groups. In all societies of the world, groups with lower life expectancy are usually in the
lowest position in the social hierarchy. This is due to a wide range of reasons. The
poorest groups have less access to health care (whether private or public), and this has a
significant impact on health. In addition, the stress to which the oppressed are subject,
harmfully affects health.
We must also consider a theory developed by Richard Wilkinson, according to
which, the fact that in the African savannah our ancestors did not live the conditions of
economic inequality that we have today, gives us difficulties in adapting to contemporary
social conditions, and this stressful mismatch generates diseases in us (Wilkison, 2002).
Moreover, Wilkinson argues that this affects not only those in lower positions, but also
the economically privileged. The pressure to maintain the status quo and resistance
against social climbers, is also harmful to health. Wilkinson documents that countries
with better health indices are not exactly the richest, but rather the most egalitarian.
Today most doctors understand diseases as a bio-psycho-social process. Under
this paradigm, disease is a multi-causal process, and must be attacked on several fronts,
not just the biological one (White, 2005). Above the biological fact of disease, there are
added layers of social construction that have a major impact on the way patients develop.
A good doctor should not only be aware of the biochemical composition of the drug
prescription; he or she should also direct his or her attention to other variables that will
have an impact on the patient’s treatment: his or her location in the social hierarchy, the
patient's willingness to continue the treatment, his or her interpretation of the disease, etc.
We should not ignore the fact that social conditions do have a considerable impact
on many diseases. And in that sense, if some racial groups appear to be more vulnerable
to a disease, it is not necessarily due to their genes; it can also be due to social position,
or in any case, some element of their culture (not registered in genes) that increases the
chances of suffering a disease.
To illustrate this argument, let us consider alcoholism among Gypsies. In Spain
and other European countries with substantial Roma population, Gypsies’ rate of
alcoholism is higher than in the rest of the population (Borani, 2002:176). What is this
about? We know that alcoholism has a genetic basis: studies with twins and adopted
children show a heredity factor of about 27% (Goodwin, 1988). But, is alcoholism among
Gypsies due to their genes?
We should not immediately dismiss this possibility, but we should also consider
some social factors that may be relevant. Gypsies have been a traditionally excluded
social group, and occupy the lowest positions in social hierarchy. We know that lack of
opportunities, unemployment, and stress about not getting social promotions; have
significant impact on alcohol consumption and eventually, alcohol dependence.
Alcoholism is clearly a disease that must be understood in a bio-psycho-social
framework.
Some critics worry that this bio-psycho-social paradigm may be abused, and
afflicted minorities to pursue victimhood status may easily use it. Critics could claim for
example, that alcoholism among Gypsies is due to many other factors, and not just due to

racism in European societies. But even if we accept this view, we are not in need of
attempting to explain diseases on the basis of their racial origins. Alcoholism is lowest in
Muslim countries: is this due to the genes of Muslim populations, or because of their
religion (a cultural factor)? The answer seems obvious.
Let us consider another example. Tuberculosis afflicts a high proportion of Native
Americans in Latin American countries (especially the Wayuu of Venezuela and
Colombia), largely because in the Native American folk understanding of diseases,
sickness is caused by spirits, and in that sense, Native Americans see no need to take
prolonged medical treatments (which is very important in the treatment of tuberculosis)
(Diaz, 2010). Should we blame racism for this situation? Not necessarily: Native
Americans themselves are responsible for not continuing treatment (it could be argued
that racism makes Native Americans refuse treatment, but for the sake of argument, let us
assume that racism has nothing to do with it). But even in that case, the cause of this high
incidence of tuberculosis among indigenous populations would be in their culture, and
not in their genes.
Ultimately, doctors do need to take into account what racial group a patient
belongs to, but not for the reasons usually cited. The medical ethics principle of justice
applies here. There is no doubt that some genetic diseases are more common in some
groups than others. However, we should not rush to assume that traditional racial traits
have an intrinsic relationship with some genes encoding particular diseases. Sickle cell
anemia, for example, has nothing to do with dark skin, but instead, with resistance to
malaria.
But the main reason why doctors should be aware of the racial affiliation of their
patients is that while human races are mostly a social construct, this social construction
has considerable effects on the health of human beings. This does not mean that social ills
are social constructs; it means that the social construction of races leads to racism, and
racism does have a significant effect on the health of people.
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